| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10598295 | Bioorganic & Medicinal Chemistry Letters | 2005 | 4 Pages |
Abstract
The incorporation of the 1-aryl-5-(4-nitrophenyl)-3-oxo-1,4-pentadienyl group into different cyclic structures led to the discovery of various compounds which displayed selective toxicity for neoplastic cells rather than normal tissues and reversed multidrug resistance.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jonathan R. Dimmock, Umashankar Das, H. Inci Gul, Masami Kawase, Hiroshi Sakagami, Zoltán Baráth, Imre Ocsovsky, Joseph Molnár,